Bharat Parenterals Limited (BOM:541096)
1,026.30
-14.60 (-1.40%)
At close: Feb 12, 2026
Bharat Parenterals Revenue
Bharat Parenterals had revenue of 651.88M INR in the quarter ending December 31, 2025, a decrease of -9.79%. This brings the company's revenue in the last twelve months to 3.50B, up 14.21% year-over-year. In the fiscal year ending March 31, 2025, Bharat Parenterals had annual revenue of 3.40B with 30.31% growth.
Revenue (ttm)
3.50B
Revenue Growth
+14.21%
P/S Ratio
2.06
Revenue / Employee
8.90M
Employees
393
Market Cap
7.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.40B | 791.65M | 30.31% |
| Mar 31, 2024 | 2.61B | 419.14M | 19.11% |
| Mar 31, 2023 | 2.19B | 69.72M | 3.28% |
| Mar 31, 2022 | 2.12B | 51.08M | 2.46% |
| Mar 31, 2021 | 2.07B | -255.76M | -10.99% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anuh Pharma | 7.68B |
| Venus Remedies | 7.03B |
| Wanbury | 6.58B |
| Sudarshan Pharma Industries | 6.44B |
| Kopran | 6.20B |
| Fredun Pharmaceuticals | 5.91B |
| Fermenta Biotech | 5.44B |
| Accent Microcell | 2.78B |
Bharat Parenterals News
- 2 months ago - Bharat Parenterals’ subsidiary Innoxel Lifesciences clears EU GMP inspection with zero observations - Business Upturn
- 2 months ago - Bharat Parenterals subsidiary Innoxel Lifesciences clears EU GMP inspection with zero observations - Business Upturn
- 3 months ago - Bharat Parenterals Ltd (BOM:541096) Q2 2026 Earnings Call Highlights: Strategic Growth Amidst ... - GuruFocus
- 3 months ago - Q2 2026 Bharat Parenterals Ltd Earnings Call Transcript - GuruFocus